热点新闻

印度将万能险更名为变额保险

    据《印度时报》报道,印度保险监管与发展署(IRDA)日前发布规定,将目前市场上所有销售的万能险更名为变额保险,并要求变额保险产品至少具有3年的锁定期间,在锁定期内不能附带任何投资连接成分。同时,变额保险不能以团体保险的方式进行销售,缴费方式不能为趸交或短期缴费形式。

    同时规定,变额保险应提供死亡保险金和保单账户余额,死亡保险金应等于保险金额。满期保险金应等于保单账户余额与终了红利(如果存在终了红利)之和。变额保险的保险金额应不低于为年交保费的10倍。

    在变额保险的成本结构上,印度保险监管与发展署规定,首年的总成本(含佣金支付)不得高于保费的27.5%。第二年和第三年的总成本(含佣金支付)不得高于保费的7.5%,从第四年开始,总成本(含佣金支付)不得高于保费的5%,且变额保险的最短保险期间和保费支付期间为5年。

    之前,万能保险一直被作为投连险的替代产品在印度市场上销售。很多客户对万能保险的销售方式不满,并向监管当局投诉。10月22日,印度保险监管与发展署表示要对万能保险市场进行监管以保护保单持有人利益,并于一个月前叫停了万能保险的销售。

   附英文原文:

    India's insurance regulator has issued comprehensive regulations governing universal life products, renaming all such products as variable insurance products (VIPs). These products are to have a lock-in period of at least three years and are barred from having any unit-linked component in them, reports The Times of India. Furthermore, VIPs cannot as of now be sold as group insurance or as single-premium or limited-premium plans.

    The Insurance Regulatory & Development Authority (IRDA) also stipulates that all VIPs should provide death benefits equal to the guaranteed sum assured plus the balance in the policy account while the maturity benefit should equal the balance in the policy account together with a terminal bonus, if any. The sum assured under these policies should be at least 10 times the annual premium.


    Outlining the cost structure of VIPs, IRDA says that the total costs, including commission, should not be more than 27.5% of the premium in the first year. The ratio is capped at 7.5% for the second and the third year and at 5% from the fourth year onwards. The minimum policy and premium payment term shall be five years.

    IRDA released the new regulations a month after it had suspended the sale of all universal life policies. On 22 October, the regulator said that there was a need to regulate the products to protect policyholders. The products had previously been marketed as an alternative to unit-linked insurance plans and the regulator said that it had received several complaints about the selling tactics of insurers marketing the universal life plans.